Prognoz qilingan narxning foydaga nisbati: Silk Road Medical Inc. (SILK)

SILK (Silk Road Medical, Inc) - kompaniyaning tovar belgisi

Silk Road Medical, Inc (SILK) tomir jarrohligi sohasidagi sikllarga bog'liq bo'lmagan talab asosida faoliyat yuritadi va inqirozlarga yuqori chidamlilikni namoyish etmoqda. GURU.Markets terminali kompaniyaning kutilayotgan foyda ko'rsatkichi (P/E) nisbatini ko'rsatadi, bunda 0.00 qiymati ushbu metrikaning joriy darajasini ifodalaydi. TCAR texnologiyasi minimal invaziv karotid arteriya davolashining oltin standartiga aylandi va Medtronic sog'liqni saqlash giganti tomonidan sotib olinishi tizimlarning yetakchiligini tasdiqladi hamda ishlanmalar bilan bog'liq xatarlarni bartaraf etdi.

silkroadmed.com - SILK Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 04.07.2022 - 28.09.2024)

Silk Road Medical (SILK) kompaniyasi koʻrsatkichlari kesimi va tahlili

- kotirovkalar va tahlilchilar prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Fundamental baholash:SILK Silk Road Medical Inc
silkroadmed.com brendining mahsuloti

Silk Road Medical, Inc (SILK) kompaniyasining forward P/E dinamikasi sug'urta to'lovlarini hisobga olgan holda, karotid arteriyasini davolash uchun TCAR tizimlari sotuvidan kutilayotgan foydaga bo'lgan bozor kutuvlarini aks ettiradi. Bozor kapitalizatsiyasining WACC ga moslashtirilgan prognoz qilingan daromadga nisbati sifatida hisoblanadigan ushbu ko'rsatkich aktivning haddan tashqari qimmat baholanganligini yoki kelajakdagi erkin pul oqimining kamayish xavfini baholash imkonini beradi.

Silk Road Medical, Inc raqobatchilari

Forvard P/E multiplikatori DXCM|Forvard P/E multiplikatori Penumbra, Inc. (PEN)|Novanta Photonics - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati HAE (Haemonetics Corporation)|INSP: Prognoz qilingan narxning foydaga nisbati|PROCEPT BioRobotics Corporation - Kapitalizatsiyaning kelajakdagi foydaga nisbati|CNMD: Forvard P/E multiplikatori|PLSE - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|INMD (inmodemd.com) - Forvard P/E multiplikatori|PMI: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati SRDX (Surmodics)|SENS (Senseonics Corp) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NeuroPace Medical NPCE|TCMD - Prognoz qilingan narxning foydaga nisbati|SANUWAVE Health - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Outset Medical, Inc. OM|ELMD: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati LNSR|RCEL (AVITA Medical Inc) - Forvard P/E multiplikatori|Profound Medical Corp. (PROF) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori BDMD|Prognoz qilingan narxning foydaga nisbati EDAP TMS EDAP|Forvard P/E multiplikatori APYX (Apyx Medical Corp)|Forvard P/E multiplikatori IceCure Medical Ltd ICCM|LUNG - Kelajakdagi narxning foydaga nisbati|TELA: Kelajakdagi narxning foydaga nisbati|CTSO (CytoSorbents Corp.) - Prognoz qilingan narxning foydaga nisbati|Sensus Healthcare, Inc. - Kelajakdagi narx-foyda multiplikatori|ZYXI (Zynex Corp) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati electrocore.com ECOR|Kelajakdagi narxning foydaga nisbati Vicarious Surgical (RBOT)|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Forvard narx-foyda multiplikatori|Forvard P/E multiplikatori ICU (seastarmedical.com)|Forvard P/E multiplikatori IRIDEX Corp. IRIX|Intelligent Bio Solutions Inc - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Beyond Air XAIR|Profusa (PFSA) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati SSKN (STRATA Skin)|Kelajakdagi narxning foydaga nisbati glucotrack.com|Prognoz qilingan narxning foydaga nisbati NanoVibronix, Inc. (NAOV)|Forvard P/E multiplikatori VERO|NUWE - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Aethlon Medical AEMD|ASXC: Narxning kelajakdagi foydaga nisbati|AVGR: Prognoz qilingan narxning foydaga nisbati|BioSig Technologies, Inc. - Kapitalizatsiyaning kelajakdagi foydaga nisbati|CUTR: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati KNW|Kelajakdagi narxning foydaga nisbati Inari Medical, Inc.|Prognoz qilingan narx-foyda nisbati Nevro Corp. NVRO|Kelajakdagi narxning foydaga nisbati ReShape Lifesciences Inc (RSLS)